Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
1120
-
Total 13F shares, excl. options
-
225M
-
Shares change
-
+17.2M
-
Total reported value, excl. options
-
$86.7B
-
Value change
-
+$6.75B
-
Put/Call ratio
-
1.16
-
Number of buys
-
686
-
Number of sells
-
-375
-
Price
-
$384.86
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q3 2021
1,275 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q3 2021.
Moderna, Inc. - COMMON STOCK (MRNA) has 1,120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 225M shares
of 385M outstanding shares and own 58.59% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (42.2M shares), VANGUARD GROUP INC (27.2M shares), BlackRock Inc. (26.9M shares), STATE STREET CORP (14M shares), FMR LLC (7.36M shares), COATUE MANAGEMENT LLC (6.05M shares), GEODE CAPITAL MANAGEMENT, LLC (5.76M shares), MORGAN STANLEY (5.66M shares), Theleme Partners LLP (3.96M shares), and NORTHERN TRUST CORP (3.46M shares).
This table shows the top 1120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.